Cargando…
A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma
Myeloperoxidase (MPO) is a circulating cardiovascular disease (CVD) biomarker used to estimate clinical risk and patient prognosis. Current enzyme-linked immunosorbent assays (ELISA) for MPO concentration are costly and time-intensive. Here we report a novel bioluminescence assay, designated MPO act...
Autores principales: | Goiffon, Reece J., Martinez, Sara C., Piwnica-Worms, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4347050/ https://www.ncbi.nlm.nih.gov/pubmed/25666092 http://dx.doi.org/10.1038/ncomms7271 |
Ejemplares similares
-
Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel Method for Optical Imaging of PET Isotopes in Biological Systems
por: Dothager, Robin S., et al.
Publicado: (2010) -
Inhibition of myeloperoxidase enhances immune checkpoint therapy for melanoma
por: Liu, Tracy W, et al.
Publicado: (2023) -
A Fluorescence-Coupled Assay for Gamma Aminobutyric Acid (GABA) Reveals Metabolic Stress-Induced Modulation of GABA Content in Neuroendocrine Cancer
por: Ippolito, Joseph E., et al.
Publicado: (2014) -
Stem cell enriched-epithelial spheroid cultures for rapidly assaying small intestinal radioprotectors and radiosensitizers in vitro
por: de la Cruz Bonilla, Marimar, et al.
Publicado: (2018) -
A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients
por: Khalilova, Irada S., et al.
Publicado: (2018)